Welcome to LookChem.com Sign In|Join Free

CAS

  • or

845-69-2

Post Buying Request

845-69-2 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

845-69-2 Usage

Description

Nordihydrocodeine, also known as a metabolite of Dihydrocodeine (D448850), is a controlled substance with specific applications in various industries. It is derived from the metabolism of Dihydrocodeine, a semi-synthetic opioid analgesic used for pain management.

Uses

Used in Pharmaceutical Industry:
Nordihydrocodeine is used as an active pharmaceutical ingredient for the development of pain relief medications. It is utilized in the formulation of drugs that target the management of moderate to severe pain, providing an alternative to other opioid analgesics.
Used in Research and Development:
In the field of pharmaceutical research and development, nordihydrocodeine serves as a key compound for studying the metabolism and pharmacokinetics of Dihydrocodeine. This helps in understanding the drug's efficacy, safety, and potential side effects, ultimately contributing to the improvement of pain management therapies.
Used in Regulatory Compliance:
As a controlled substance, nordihydrocodeine is used in regulatory compliance and monitoring efforts to ensure the responsible distribution, prescription, and use of opioid analgesics. This helps in preventing the misuse and abuse of these potent pain relievers, safeguarding public health and addressing the ongoing opioid crisis.
Used in Toxicology and Forensic Analysis:
Nordihydrocodeine plays a role in toxicology and forensic analysis, where it is identified and quantified in biological samples to determine the presence and levels of Dihydrocodeine and its metabolites. This is crucial in cases of drug overdose, poisoning, or substance abuse investigations, aiding in the legal and medical assessment of such incidents.

Check Digit Verification of cas no

The CAS Registry Mumber 845-69-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,4 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 845-69:
(5*8)+(4*4)+(3*5)+(2*6)+(1*9)=92
92 % 10 = 2
So 845-69-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H21NO3/c1-20-13-5-2-9-8-11-10-3-4-12(19)16-17(10,6-7-18-11)14(9)15(13)21-16/h2,5,10-12,16,18-19H,3-4,6-8H2,1H3/t10?,11-,12+,16?,17+/m1/s1

845-69-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (6α)-3-Methoxy-4,5-epoxymorphinan-6-ol

1.2 Other means of identification

Product number -
Other names N-Norcodeine hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:845-69-2 SDS

845-69-2Downstream Products

845-69-2Relevant articles and documents

-

Perrine,Small

, p. 111 (1956)

-

PROCESS FOR REDUCING THE 6-KETO GROUP OF A MORPHINAN ALKALOID TO THE 6-HYDROXY GROUP BY HYDROGENATION

-

Page/Page column 4-5, (2011/04/13)

The present invention relates to a process for the reduction of a 6-keto group in a morphinan alkaloid to the corresponding 6-hydroxy group, comprising hydrogenating the 6-keto group using gaseous hydrogen in the presence of a heterogeneous catalyst and a solvent, to yield the 6-hydroxy morphinan alkaloid, wherein the reduction is carried out at a pH in the range of about 5 to about 7, and the 6-hydroxy morphinan alkaloid has an α:β ratio of > 85: 15.

Metabolism and pharmacokinetics of dihydrocodeine in dog

Konishi,Shiono,Ohno,Takahashi,Aoki

, p. 591 - 601 (2007/10/03)

The metabolism and pharmacokinetics of dihydrocodeine have been studied in dog. Urinary metabolites after oral administration of dihydrocodeine were identified using hplc with diode-array and ms. In urine, dihydronorcodeine, dihydromorphine and dihydrocodeine glucuronide were identified in comparison with their authentic standards, and dihydronorcodeine 6-glucuronide also appeared to be excreted as a metabolite. The major urinary metabolite was dihydrocodeine glucuronide, recovered as 49% of the dose, and other metabolites were found to be 0.1-3%, 24h after 3 mg/kg oral administration of dihydrocodeine. Plasma concentrations of unchanged dihydrocodeine were significantly lower after oral rather than intramuscular administration, the maximum concentrations were 40 and 549 ng/ml after oral and intramuscular administration, respectively. This suggests that dihydrocodeine was metabolized via a hepatic first-pass effect after oral administration. Overall, our results indicate that the metabolic pathways of dihydrocodeine in dog were similar to that of codeine metabolism in animals and man.